1. Introduction
These days, good appearance is one of advantages in human relationship, however a lot of people aresuffering hair losing called alopecia disease. The additional problem is the increasing number of alopeciapatients in Taiwan,1 United States of America,2 France, Germany, Italy, the United Kingdom3 and Korea4 and so on. Various factors such as emotional distress and anxiety may incur the loss of hair.5 In addition, synthetic chemical products sold in the market including shampoo to clean scalp can causehair-losing problem due to their chemical irritation on scalp and skin.6 Therefore, more natural and skin-friendly products are interested and required by consumers. In accordance with the demand of customers, a new scalp tonic formulation was developed using natural herb extract.
A new scalp tonic formulation was developed with the extract of Pulsatillae Radix (PR) and other herbs. PR extract is main component of scalp tonic. PR is atraditional herbal drugs and defined as the root of Pulsatilla koreana Nakai or P. chinensis Regel(Ranunculaceae). 7 It has been widely used to treat bacterial infections, intestinal amebiasis8,9 around in China, Korea and other eastern Asia countries. PR has been known as a medicinal herb to treat tumorand endotoxin.10
PR contains numerous compounds, including phytosterone 11 and triterpenoid saponins.12 Oleanolicacid is one of main compounds in this herb,13 whichis a pentacyclic triterpenoid and owns various biologicalactivities such as antioxidant, exhibiting potentantitumor and antibacterial activities and so on.14-19 Itinvolved into the hair regrowth in clinical experiment, 20therefore, oleanolic acid is used as a main component insome patents for the treatment of baldness hair lossor hair regrowth.21,22 Recently, therapeutic components are chosen as a chemical marker to apply forqualitative and quantitative evaluation.23 Considering the bioactivity of alopecia treatment, oleanolic acid can be a key compound to determine the bioactivity and marker compound for the standardization and quality control of commercial scalp tonic. Therefore, oleanolic acid was selected as a marker compound in this study.
Up to now, several HPLC methods have been reported to quantify oleanolic acid contents in PR extract, 24-26 but there is no HPLC method to analyzeoleanolic acid in PR and commercial products containing PR extract together. The quantitation of target compound in herb extract and commercial herbal products is completely different. Even thoughan analytical method can analyze marker compoundsin herb, it is still hard to be used for quantify and qualify markers in commercial herbal products due to the different chemical compositions between herband commercial herbal products. The problem of maker detection induces the standardization and quality control of herbal product and it interrupts tocommercialize a natural product frequently.
The aim of this study is to develop a rapid andeffective HPLC analytical method to apply both PR extract and scalp tonic product, qualitatively and quantitatively. Extraction conditions such as concentration of sulfuric acid and extraction time were optimized through a response surface methodology (RSM), which is an effective and powerful tool foroptimizing experimental conditions due to its logical validity over a minimal number of runs. Optimum conditions were elucidated through central compositedesign (CCD), which is widely used because of its practical design. Oleanolic acid peak were identified from LC-ESI-MS by their spectral characteristics and by comparing with standard signatures.
2. Materials and Methods
2.1. Chemicals and reagents
Four scalp tonic products were made by a cosmeticcompany in Korea and coded EG01, EG02, EG03and EG04 with different PR extract contents, EG01 is the only one without PR extract. Acetonitrile, methanol and ethyl acetate were purchased (HPLC grade) from Burdick & Jackson (Morris Plains, NJ, USA). Sulfuric acid and formic acid were obtained from Daejung Chemicals & Metals (Siheung, Korea). Oleanolic acid having purity of 98 % was purchased from ALB Technology (HongKong, China) forstandard and its structure was shown in Fig. 1. Distilled water of over 18 MΩ was purified by Milli-Q purification system (Sinhan, Seoul, Korea). Syringefilter (25 mm, 0.22 µm, PVDF membrane) were made by Woongki Science (Seoul, Korea). All samples were stored at 4 oC before use.
Fig. 1. The chemical structure of oleanolic acid.
2.2. Preparation of sample and standard solutions
PR (0.1 g) and scalp tonic solution (5 mL) wereaccurately weighted, and 10.0 mL of 2.8 M sulfuricacid was added to each sample for extraction. The solution was refluxed in water bath at 95 oC for 76 min. After cool down in the air, the solution was partitioned by adding 15.0 mL of ethyl acetate threetimes for liquid-liquid extraction. All ethyl acetatelayers were combined together and evaporated to dry. 1.0 mL of methanol was added to dissolve the dried extract. This solution was filtered by 0.22 µm PVDF filter. 1.0 mg of oleanolic acid standard was dissolved in 1.0 mL methanol for stock standardsolution and storage at 4 oC. Working standard solution was prepared by diluting the stock solution with methanol.
2.3. Development of HPLC method
HPLC analysis was carried out on a ShimadzuLC-20AD series system (Kyoto, Japan) using an Optimapak C18 column (4.6 × 250 mm, 5 µm, R Stech, Korea) with mobile phase of 0.1 % formic acid in water (A) and 0.1 % formic acid in acetonitrile (B) at 35 oC. The elution condition (isocratic or gradient) and flow rate (0.5 mL/min to 1.0 mL/min) of mobile phase were optimized with several different HPLCruns. Overall consideration, the gradient program was with 95-99 % B at 0-8 min, 99 % B at 9-21 minand 99-95 % B at following 1 min, at a mobile phaseflow rate of 0.5 mL/min and an injection volume of 5 μL.
2.4. Identification of oleanolic acid in sample by LC-ESI-MS.
To identify oleanolic acid in sample, mass spec-trometric experiment was performed using ShimadzuLCMS-8040 system under ESI (electrospray ionization) interface mode. Mass condition was set drying gas (N2) of 10 L/min at 200 oC, nebulizing gas of 3.0 L/min, the heat block temperature of 350 oC, the interface voltage of 3.5 kV in positive and negative mode. The other parameters were same as HPLC-UV conditions.
2.5. Optimal extraction conditions
For optimizing extraction efficiency of samples, response surface methodology (RSM) was performed based on the result of preliminary one-variable-at-a-time (OVAT). Acid types, different acid concentrations, hydrolysis time and material-solvent ratio were examined on OVAT experiments. According to the quantitation result of preliminary experiments, tworemarkable factors were selected and designed as X1: concentration of sulfuric acid (1.0, 3.0 and 5.0M), X2: extraction time (30, 60 and 90 min) for the further central composite design (CCD). Totally, 13 runs containing 5 replicates of central points, 2 variables at three levels (low, medium and high) and responses from these experiments (Y) were designed. The results were shown in Table 1. All data wereanalyzed by Design Expert Software Ver. 10 (30 trialversion, Stat-Ease Inc., Minneapolis, Minnesota, USA). The model with the largest effect demonstrated the maximum values of each factor, and it was inferred from the three-dimensional response surface.
Table 1. Two-variables for central composite design
2.6. HPLC method qualification
Linearity, limit of detection (LOD), limit of quantitation (LOQ), precision, accuracy, repeatability and recovery were performed for method qualification. Linearity was verified by the coefficient of determination (r2) of calibration curve between a series of standardsolution and its corresponding peak area. LOD and LOQ were determined the concentration at thesignal-to-noise ratio of 3:1 and 10:1 respectively. Accuracy and precision were evaluated at low, medium and high concentration of standard solutionfive times a day for intra-day and five consecutivedays for inter-day. Precision was expressed relativestandard deviation (RSD). Repeatability was examined by six continuous injections of sample and evaluated with value of RSD. Recovery was determined by spiking the known concentration in three levels (80 %, 100 % and 120 %) in sample solution. The fortified sample were dealt with same procedure as described in section 2.2. The result was calculated as recovery (%) = amount found/ (amount original +amount spiked) × 100 %. All results were expressed with RSD value.
3. Results and Discussion
3.1. Optimization of HPLC conditions
According to publications, acetonitrile is good formobile phase to detect oleanolic acid in natural herb,27 and in this research, wavelength was set at 200 nm, therefore water-acetonitrile was selected asmobile phase. Furthermore, adding formic acid, 0.1 % aqueous formic acid-acetonitrile showed bettershape and symmetry of peak than water-acetonitrile. Comparing the resolution and other factors, gradient mode with 0.5 mL/min was adapted instead of 1 mL/min. Except 0.5 mL/min, other flow rate cannot be used to separate oleanolic acid with its front impuritypeak. The effect of flow rate on retention time and resolution between oleanolic acid peak and impuritypeaks was shown in Fig. 2. With the flow rate of 0.5 mL/min, the gradient elution program was set as follows: initial 0-8 min, mobile phase B changed from 95 % to 99 %; the following 12 min, B waskept at 99 %; B inclined back to 95 % in next 1 min. Another 10 min was required to equilibrate the column. Totally, 30 min was needed and the injection volume of each sample was 5 µL. Retention time of oleanolicacid standard and samples were all eluted at 17.0 min. Samples were analyzed by LC-ESI-MS to identify the oleanolic acid. The pseudo-molecularions at 17.0 min in MS spectrum were m/z 439 [M-H2O+ H]+ and m/z 457 [M+H]+ in positive mode, and m/z 455 [M-H]− in negative mode (Fig. 3). It indicated that the detected compound was oleanolic acid. Additionally, same mass-to-charge ratio has beenobserved to do identification of oleanolic acid inpublished papers.24
Fig. 2. Effect of flow rate on retention time of oleanolic acid and resolution of oleanolic acid and next available peak.
Fig. 3. LC-ESI-MS spectrum of oleanolic acid in sample at positive and negative mode.
3.2. Optimization of extraction of PR and product
The central points of two factors, sulfuric acid concentration and extraction time, were decided as mentioned in section 2.5, as 3.0 M and 60 min, respectively. From 13 experiments, built on 2-factor, 3-level CCD were used to design the three-dimensional model (Fig. 4). The maximum yield obtained from the optimal conditions values of two variables by RSM were 2.8 M sulfuric acid and 76 min of extractiontime. The relationship between the two factors and peak area (Y) was positive at the beginning and finallygot a form of parabola. However, their relation becamenegative and this was considered as the result of the dissolution of other constituents and high temperaturescaused by extraction to marker compounds. Responsesurface methodology is one of the multivariable statistictechniques to figure out the optimal condition including the interactive effects among the variable parameters.
The experiment was performed under the optimized conditions obtained by RSM model and the results were in accordance with the predicted values, indicating that the applied RSM model in this study was suitable for sample preparation (Table 2).
Table 2. Comparison between experimental and RSM values for analytical sample preparation (n=3)
Fig. 4. Optimal extraction condition of scalp tonic by 3D response surface methodology.
3.3. HPLC method qualification
Linearity was evaluated at seven different concen-trations of standard solution diluted with 100 % methanol. The coefficient of determination (r2) was 0.9997 and it indicated that peak area and the concentration of marker compound showed good linearity in the concentration range of 0.1 to 120 mg/mL. LOD and LOQ were estimated as 17.5 ng/mLand 55.0 ng/mL, respectively. Intraday accuracy and precision were verified at three different concentrations (0.6, 12.5 and 100 mg/mL) of standard solution fivetimes in a day. Inter-variabilities were performed infive consecutive days. Accuracies of intra-day andinter-day were 99.5 % to 100.9 % and 100.0 % to 102.2 %, respectively. Precisions of them were 0.5 % to 1.4 % RSD and 0.7 % to 1.8 % RSD (Table 3). As shown in Table 4, recovery of each sample was atacceptable range. Sample preparation process wassuitable because of low loss of marker compoundand high extraction efficiency of marker compound during sample treatment. In overall, the developed method is well qualified in accordance with the guidelines of China and Korea.28-29
Table 3. Intra-/inter-day accuracy and precisions of oleanolic acid (n=5)
Table 4. Recovery of the developed method (n=3)
3.4. Application for the quality control of scalp tonic products
The qualified method was applied to the developed scalp tonic products, and as shown in Fig. 5, the marker compound, oleanolic acid, could be base lineseparated from other matrices in the products. EG01 showed no peak at 17.0 min, indicating that blanksample contains no oleanolic acid, while the markercompound could be determined from PR extract, EG02, EG03 and EG04 samples. The concentration of oleanolic acid in products could be converted into the concentration of PR extract using the concentration of oleanolic acid in the PR extract (156.9±0.7 mg/g). As shown in Table 5, the concentrations of PR extract in the products, EG02, EG03 and EG04 were 0.157 %. 0.305 % and 1.61 %, respectively.
Fig. 5. HPLC chromatograms of (a) oleanolic acid standard, (b) EG01 and (c) EG04 solution. HPLC conditions: column; Optimapak C18 (4.6 × 250 mm), mobile phase; 0.1 % formic acid in water (A) and 0.1 % formic acid in acetonitrile (B), gradient program; 0 min 95 %B, 8 min 99 % B; 20 min 99 %B, flow rate; 0.5 mL/min, column temp.; 35 o C, Peak: 1. Oleanolic acid.
4. Conclusions
This study was performed to develop a simple HPLC method for standardization and quality controlof commercial scalp tonic product containing PR extract. The selected marker compound (oleanolicacid) was suitable for the quality control of PR and scalp tonic. The optimal conditions of analytical sample estimated by RSM coupled with CCD were 2.8 M sulfuric acid and 76.0 min of extraction time by sonication. The developed method was useful to apply for the quality control PR extract and scalptonic together by qualitative and quantitative analysis. In addition, the developed method can be applied toset up efficiently for the quality control of othertonics and liquid products based on PR extract.
Acknowledgements
This work was supported by the research funds from Chungnam National University (Daejeon, Republic of Korea).
References
- L. H. Su, L. S. Chen, and H. H. Chen, J. Am. Acad. Dermatol., 69(2), 69-77 (2013). https://doi.org/10.1016/j.jaad.2012.09.046
- R. C. Gathers and M. G. Mahan, J. Clin. Aesthet. Dermatol., 7, 26-29 (2014).
- M. Alfonso, H. Richter-Appelt, A. Tosti, M. S. Viera, and M. Garcia, Curr. Med. Res.Oper., 21, 1829-1836 (2005). https://doi.org/10.1185/030079905X61820
- S. J. Yun, J.-W. Lee, H.-J. Yoon, S. S. Lee, S.-Y. Kim, J.-B. Lee, S.-C. Lee, Y.-H. Won, and S.-J. Kim, J. Dermatol., 34, 451-455 (2007). https://doi.org/10.1111/j.1346-8138.2007.00309.x
- P. Mirmirani, Maturitas, 74(2), 119-122 (2013). https://doi.org/10.1016/j.maturitas.2012.10.020
- J. R. Barrett, Environ. Health. Perspect., 113, A24 (2005).
- Ministry of Food and Drug Safety, Korean Herbal Pharmacopeia. Part III, pp. 156-157, Republic of Korea (2015).
- Y. Ling, Z. Lin, W. Zha, T. Lian, and S. You, Phytochem. Anal., 27, 174-183(2016). https://doi.org/10.1002/pca.2613
- L. Cheng, M. Zhang, P. Zhang, Z. Song, Z. Ma, and H. Qu, Rapid Commun. Mass. Spectrom., 22, 3783-3790 (2008). https://doi.org/10.1002/rcm.3801
- H. Xu, X. Shi, X. Ji, Y. Du, H. Zhu, and L. Zhang, J. Sep. Sci., 34, 308-316 (2011). https://doi.org/10.1002/jssc.201000660
- H.-J Xu, X.-W. Shi, Y.-F. Du, H. Zhu, and L.-T. Zhang, Food Chem., 135, 251-258 (2012). https://doi.org/10.1016/j.foodchem.2012.04.081
- S. C. Bang, Y. Kim, J. H. Lee, and B. Ahn, J. Nat. Prod., 68, 268-272 (2005). https://doi.org/10.1021/np049813h
- X. Ding, 'Chemical component study of China medicine-Baitouweng', Master thesis, Soochow University, Suzhou, Taipei (2010).
- J. Li, W.-J. Guo, and Q.-Y. Yang, World J. Gastroenterol., 8, 493-495 (2002). https://doi.org/10.3748/wjg.v8.i3.493
- S.-J. Tsai and M.-C Yin, J. Food Sci., 73, H174-H178 (2008). https://doi.org/10.1111/j.1750-3841.2008.00864.x
- X. Wang, H. Bai, X. Zhang, J. Liu, P. Cao, N. Liao, W. Zhang, Z. Wang, and C. Hai, Carcinogen., 34, 1323-1330 (2013). https://doi.org/10.1093/carcin/bgt058
- J. Pollier and A. Goossens, Phytochem., 77, 10-15 (2012). https://doi.org/10.1016/j.phytochem.2011.12.022
- K. I. Wolska, A. M. Grudniak, B. Fiecek, A. Kraczkiewicz-Dowjat, and A. Kurek, Cent. Eur. J. Biol., 5, 543-553 (2010). https://doi.org/10.2478/s11535-010-0045-x
- J. A. Jesus, J. H. G. Lago, M. D. Laurenti, E. S. Yamamoto, and L. F. D. Passero, Evidence-Based Complement. Altern. Med., 2015, ID.620472 (2015).
- M. Suzuki, Y. Ninagawa, K. Hosokawa, K. Matsunaga, and R. Hayakawa, Skin, 31(4), (1989).
- K. Lintner, C. Maschamberlin, Patent, US20060067905 (2006).
- T. Cabanas, Carles, Foyaca Ferrer, Monica, "Anti-hair loss lotion", Patent, WO2017021247, 2017.
- S. Li, Q. Han, C. Qiao, J. Song, C. L. Cheng, and H. Xu, Chin. Med., 3, Doi: 10.1186/1749-8546-3-7, 2008.
- Q. Chen, Y. Zhang, W. Zhang, and Z. Chen, Biomed. Chromatogr., 25),1381-1388 (2011). https://doi.org/10.1002/bmc.1614
- L. Zhao, W. Li, Y. Li, H. Xu, L. Lv, X. Wang, Y. Chai, and G. Zhang, J. Chromatogr. Sci., 53, 1185-1192 (2015). https://doi.org/10.1093/chromsci/bmu217
- J. Peragon, E. E. Rufino-Palomares, I. Munoz-Espada, F. J. Reyes-Zurita, and J. A. Lupianez, Int. J. Mol. Sci., 16, 21681-21694 (2015). https://doi.org/10.3390/ijms160921681
- V. Aeri, M. I. Khan. and S. Alam, Int. J. Pharm. Pharmaceut. Sci., 2, 74-78 (2010).
- The State Commission of Pharmacopoeia, Pharmacopeia of People's Republic of China, The Medicine Science and Technology Press of China, Beijing, PRC, Part I, 163, People's Republic of China (2015).
- Ministry of Food and Drug Safety, Korean Pharmacopoeia, Part II, p.1851, Republic of Korea (2015).